ICD-10 Code L03.311: Cellulitis of Abdominal Wall – Complete Coding & Billing Guide

What Does ICD-10 Code L03.311 Mean?

ICD-10 code L03.311 designates a diagnosis of cellulitis of the abdominal wall — a bacterial infection of the deep dermis and subcutaneous tissue localized to the anterior or lateral abdominal surface. This code is a billable, valid ICD-10-CM diagnosis code classified under Chapter 12 (Diseases of the Skin and Subcutaneous Tissue), within the subsection L00–L08 (Infections of the Skin and Subcutaneous Tissue).

Key attributes at a glance:

• Billable: Yes — valid for HIPAA-covered claim submission FY 2026 (October 1, 2025–September 30, 2026)
• Code first / Use additional: A “use additional code” instruction applies when identifying an infectious organism (e.g., B95–B96 series)
• Applicable setting: Inpatient and outpatient
• MS-DRG assignment: Groups to MS-DRG 573, 574, or 575 (Skin Graft for Skin Ulcer or Cellulitis, with/without MCC/CC) when surgical management is involved
• Electronic submission: Submit as L03311 without the decimal point to avoid claim rejection

What Conditions and Diagnoses Does L03.311 Cover?

L03.311 applies when the documented site of bacterial skin infection is the abdominal wall — which clinically refers to the layers of skin, subcutaneous fat, and fascia covering the anterior and anterolateral abdomen. This is one of the more clinically significant trunk cellulitis sites because abdominal wall infections frequently arise in post-surgical or post-procedural contexts.

Clinical presentations appropriately captured under L03.311 include:

• Spontaneous bacterial cellulitis of the anterior abdominal wall without an identifiable portal of entry
• Post-operative wound cellulitis following abdominal surgeries (laparotomy, hernia repair, cesarean section, bariatric procedures)
• Cellulitis complicating colostomy or ileostomy stoma sites on the abdominal wall
• Abdominal wall infection secondary to trauma, abrasion, or bite wound
• Cellulitis associated with subcutaneous insulin injection sites on the abdomen
• Infected panniculitis of the abdominal wall when the predominant finding is cellulitis

What Does L03.311 Specifically Exclude?

Several anatomically adjacent or clinically similar conditions are excluded from L03.311 and require separate codes. The following are Excludes2 conditions (meaning the patient may have both simultaneously, but separate coding is required):

• Omphalitis / umbilical cellulitis — code to L03.316 (Cellulitis of umbilicus)
• Cellulitis of the groin — code to L03.314
• Cellulitis of the perineum — code to L03.315
• Cellulitis of the buttock — code to L03.317
• Puerperal cellulitis of the breast — code to O91.2
• Omphalitis of newborn — code to P38.-
• Cellulitis of female external genital organs — code to N76.4

In practice, coders frequently encounter ambiguous documentation where a provider notes “abdominal cellulitis” without specifying whether the umbilicus is involved. Always query the provider or review imaging/nursing notes to distinguish L03.311 from L03.316 before final code assignment.

When Is L03.311 the Right Code to Use?

Selecting L03.311 requires confirmation that the documented infection meets both anatomical site and clinical type criteria. Use this numbered checklist to validate correct code selection:

1. Confirm the anatomical site is the abdominal wall. The provider must explicitly document “abdominal wall” as the infected area — not simply “abdomen” or “abdominal.”
2. Confirm the diagnosis is cellulitis, not abscess. If the provider documents a loculated fluid collection, abscess, or I&D-treated lesion, consider L02.211 (Cutaneous abscess of abdominal wall) instead of L03.311.
3. Rule out excluded anatomical sub-sites. Verify that the infection does not involve the umbilicus, groin, perineum, or buttock — all of which carry separate, more specific codes within the L03.31x series.
4. Verify this is not a neonatal condition. Newborn abdominal wall infections (particularly omphalitis) are coded with pediatric-specific codes under P38.
5. Assign organism code if documented. If the responsible pathogen is identified (e.g., MRSA, Group A Streptococcus), append the appropriate code from the B95–B96 category per the “use additional code” instruction.

How Does L03.311 Differ From L03.316 (Cellulitis of Umbilicus)?

The L03.31x subcategory is granular, and the distinction between abdominal wall and umbilical cellulitis is one of the most common selection errors coders encounter at this level.

When a provider documents “periumbilical cellulitis” without further clarity, query for specificity before defaulting to L03.311.

What Documentation Is Required to Support L03.311?

Inadequate documentation is the primary reason L03.311 claims are denied or flagged during coding audit preparation. The provider record must substantively support both the diagnosis and the specific anatomical site.

What Must the Provider Document in the Clinical Notes?

The following elements are required or strongly recommended to support L03.311:

1. Explicit anatomical site language — “abdominal wall” must appear in the provider’s assessment/plan or problem list
2. Classic cellulitis findings — erythema, warmth, edema, and tenderness of the abdominal wall documented in the physical exam
3. Clinical differentiation from abscess — note whether fluctuance is present or absent; if an I&D was performed, abscess coding (L02.211) may apply instead
4. Documented or suspected etiology — portal of entry (surgical wound, skin break, stoma) or notation of spontaneous onset
5. Response to treatment — antibiotic prescribed and clinical response supports medical necessity
6. Relevant comorbidities — diabetes (E11.xx), obesity (E66.xx), or immunosuppression that may affect severity or treatment intensity should be co-coded

Which Diagnostic or Lab Results Support This Code?

Laboratory and imaging findings are not required to assign L03.311, but they strengthen medical billing documentation requirements for high-acuity encounters:

• CBC with differential — leukocytosis supports infectious/inflammatory process
• CRP or ESR — elevated inflammatory markers corroborate systemic infection
• Blood cultures — positive results may prompt organism-specific coding (B95–B96)
• Wound culture — pathogen identification enables more precise additional coding
• CT abdomen/pelvis — used to rule out deeper infection (necrotizing fasciitis, abscess), and imaging reports should be reviewed for site confirmation
• Ultrasound — differentiates cellulitis from fluid collection/abscess

What Is the Documentation Standard for Inpatient vs. Outpatient Settings?

This distinction is critical when a patient is admitted with “possible abdominal wall cellulitis” — the outpatient coder cannot assign L03.311 without confirmed diagnosis, but the inpatient coder can if the attending documents it as a working or discharge diagnosis.

How Does L03.311 Affect Medical Billing and Claims?

Understanding how L03.311 flows through the revenue cycle helps billers anticipate payer behavior and reduce avoidable denials.

Key billing and payer considerations:

• Medical necessity must be supported by clinical documentation consistent with cellulitis — vague “skin infection” notes without site specificity create medical necessity risk
• Severity drives DRG assignment — when L03.311 is the principal inpatient diagnosis, the presence of MCCs (e.g., sepsis, uncontrolled diabetes) or CCs moves the case from DRG 575 to 574 or 573, materially affecting reimbursement
• Outpatient E/M level justification — the complexity of the cellulitis (extent of erythema, systemic symptoms, comorbidities) should align with the E/M level billed
• NCCI edits — certain wound care and debridement CPT codes may have bundling considerations when billed with L03.311; verify against the National Correct Coding Initiative edits before submission

What CPT or Procedure Codes Are Commonly Billed With L03.311?

Are There Any Prior Authorization or Coverage Restrictions?

• Most payers do not require prior authorization for E/M visits coded with L03.311
• IV antibiotic infusion in an outpatient infusion center may require prior authorization under some commercial plans
• Inpatient admission for cellulitis is subject to InterQual or MCG criteria — document severity markers (spreading erythema despite oral antibiotics, systemic SIRS, inability to tolerate oral medications) to support admission necessity
• Medicare does not have a National Coverage Determination (NCD) specific to cellulitis treatment; medical necessity is governed by local coverage policies

What Coding Errors Should You Avoid With L03.311?

Cellulitis of the trunk is a high-frequency coding area, and L03.311 in particular sees consistent error patterns in both claim submission and audit review. The following are the most common mistakes, ranked by audit risk:

1. Using L03.90 (Cellulitis, unspecified) when the site is documented — any time the provider specifies “abdominal wall,” the unspecified code is an undercoding error that reduces diagnosis code specificity and may trigger a query from payers
2. Confusing cellulitis with abscess — assigning L03.311 when the note documents a fluctuant, drained, or I&D-managed lesion; the correct principal code in those cases is typically L02.211
3. Omitting the organism code — failing to append a B95 or B96 code when the pathogen is clearly documented in culture results
4. Coding L03.311 for neonatal abdominal wall infection — newborn omphalitis and abdominal wall infections are coded to P38.-, not adult cellulitis codes
5. Sequencing errors in post-procedural cellulitis — when cellulitis is the complication of a surgical wound, payers and auditors expect a complication code (T81.4xx-) as the principal diagnosis in many inpatient scenarios, with L03.311 as secondary
6. Using L03.311 for intra-abdominal infections — cellulitis in ICD-10 refers to skin and subcutaneous tissue; infections of the peritoneum, fascia, or abdominal viscera are coded elsewhere (e.g., K65.0, M72.6)

What Do Auditors Look for When Reviewing Claims With L03.311?

During revenue cycle compliance reviews, auditors specifically examine:

• Whether the physical exam documents site-specific findings (erythema, warmth, induration) localized to the abdominal wall — not just “abdominal tenderness”
• Whether an abscess was present but not identified, which would change the principal diagnosis
• Whether organism identification in the record was reflected in the code set
• Whether outpatient claims coded L03.311 as a “suspected” or “probable” diagnosis (not permitted outpatient)
• Whether the E/M level billed is supported by the documented complexity of the encounter

How Does L03.311 Relate to Other ICD-10 Codes?

L03.311 sits within a structured anatomical framework of trunk cellulitis codes that coders must navigate precisely.

What Is the Correct Code Sequencing When L03.311 Appears With Other Diagnoses?

1. Post-procedural abdominal wall cellulitis (inpatient): Sequence T81.41x- (Infection following a procedure) first, then L03.311 to identify the site, then B95/B96 if organism is documented.
2. Cellulitis in a diabetic patient: Sequence L03.311 first (reason for the encounter), then the appropriate diabetes code (E11.618 — type 2 DM with other diabetic skin complication, or E11.10 if complicated by ulcer) per ICD-10-CM Official Coding Guidelines Section I.C.4.
3. Cellulitis with sepsis: Per coding guidelines, sepsis (A41.xx) is sequenced before L03.311 when sepsis is the principal diagnosis.
4. MRSA cellulitis: L03.311 + B95.62 (MRSA as the cause of disease classified elsewhere).

Real-World Coding Scenario — How L03.311 Is Applied in Practice

Patient Encounter: A 58-year-old male with type 2 diabetes presents to the emergency department three weeks following open inguinal hernia repair. He reports four days of increasing redness, warmth, and swelling of the lower abdominal wall near the incision site. The attending documents “abdominal wall cellulitis, post-operative, no abscess identified on bedside ultrasound.” Blood culture is drawn; CBC shows leukocytosis. He is admitted for IV vancomycin empirically pending culture results. Wound culture subsequently identifies MRSA.

Correct Code Application

• T81.41XA — Infection following a procedure (initial encounter; principal diagnosis for inpatient admission)
• L03.311 — Cellulitis of abdominal wall (identifies site of infection)
• B95.62 — MRSA as the cause of disease classified elsewhere (organism identified on culture)
• E11.9 — Type 2 diabetes mellitus without complications (relevant comorbidity affecting management)

Common Mistake in This Scenario

• Incorrect: Assigning L03.311 as the principal diagnosis and omitting T81.41XA
  • Why it fails: The cellulitis is a direct complication of the surgical procedure, and ICD-10-CM Official Coding Guidelines direct coders to sequence the post-procedural complication code first in inpatient records when the complication is the reason for the admission
• Incorrect: Omitting B95.62 after culture results are finalized in the record
  • Why it fails: When the responsible organism is documented anywhere in the medical record, the use additional code instruction for organism identification applies — failure to code it is an omission that auditors flag

Frequently Asked Questions About ICD-10 Code L03.311

Is ICD-10 Code L03.311 Valid for Use in 2026?

ICD-10 code L03.311 is a valid, billable diagnosis code for fiscal year 2026, effective October 1, 2025 through September 30, 2026, with no changes to its description or validity status since its introduction in FY 2016. Coders should verify code validity annually against the CMS ICD-10-CM tabular updates released each October.

What Is the Difference Between L03.311 and L02.211?

L03.311 designates cellulitis of the abdominal wall — a diffuse bacterial infection of the dermis and subcutaneous tissue without a discrete fluid collection. L02.211 designates a cutaneous abscess of the abdominal wall, which involves a walled-off pus-containing lesion typically requiring incision and drainage. The critical clinical distinction is whether fluctuance, loculated fluid, or a drained cavity is documented.

Can L03.311 Be Used for Post-Operative Wound Infections?

L03.311 can be used to identify the site of a post-operative abdominal wall infection, but it should be sequenced as a secondary code in inpatient claims when a post-procedural complication code (T81.41x-) is applicable. In outpatient settings, sequencing depends on the primary reason for the visit; when the wound infection is the chief complaint, T81.41x- is typically the first-listed diagnosis.

Do I Need to Code the Organism Separately When Using L03.311?

Yes — if the infectious organism is documented anywhere in the medical record (assessment, culture results, or provider notation), the ICD-10-CM Official Coding Guidelines instruct coders to append an additional code from the B95–B96 series. Common pairings include B95.61 (MSSA), B95.62 (MRSA), B95.1 (Group A Streptococcus), and B96.89 (other specified bacterial agents).

Is L03.311 Covered by Medicare?

Medicare covers medically necessary treatment for cellulitis of the abdominal wall under standard medical benefit rules; there is no NCD restricting coverage. Coverage determinations hinge on whether the documentation supports the diagnosis and the level of service billed. IV antibiotic therapy in an outpatient infusion setting may be subject to local coverage determination (LCD) requirements, which vary by Medicare Administrative Contractor (MAC).

What Is the Difference Between L03.311 and L03.90?

L03.90 represents cellulitis of an unspecified site and should only be used when the provider’s documentation genuinely does not identify the anatomical location. When documentation explicitly states “abdominal wall,” use of L03.90 is an undercoding error that fails diagnosis code specificity standards and may trigger a claim edit or audit finding.

Can L03.311 and L03.316 Be Coded Together?

Yes — if a patient has documented cellulitis of both the abdominal wall and the umbilicus as distinct, separately described sites, both L03.311 and L03.316 may be assigned. However, if the documentation is ambiguous (e.g., “periumbilical cellulitis”), query the provider for anatomical specificity before assigning both codes.

Key Takeaways

• L03.311 is a highly specific, billable code for cellulitis of the abdominal wall — never substitute L03.90 when the site is documented.
• The L03.31x subcategory contains eight distinct trunk cellulitis codes; selecting the correct one requires careful attention to the exact documented anatomical site.
• Post-procedural abdominal wall cellulitis requires sequencing T81.41x- first in inpatient claims, with L03.311 as the site identifier.
• When organism identification is documented anywhere in the record, a B95–B96 code must be appended per the use additional code instruction.
• Cellulitis (L03.311) and abscess (L02.211) are mutually exclusive conditions — the presence or absence of fluctuance and drainage determines which code applies.
• Inpatient coders may code “probable” abdominal wall cellulitis at discharge; outpatient coders may not.
• For complete official guidance, consult the CMS ICD-10-CM Official Coding Guidelines and the AHA Coding Clinic for scenario-specific advice.